Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Conmed Q4 Earnings

Conmed (NYSE:CNMD) reported its Q4 earnings results on Wednesday, January 31, 2024 at 04:05 PM. Here’s what investors…
byBenzinga Insights
January 31, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

Conmed (NYSE:CNMD) reported its Q4 earnings results on Wednesday, January 31, 2024 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Conmed missed estimated earnings by 4.5%, reporting an EPS of $1.06 versus an estimate of $1.11.

Revenue was up $76.18 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 2.95% increase in the share price the next day.

Here’s a look at Conmed’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.83 0.79 0.60 0.90
EPS Actual 0.90 0.83 0.66 0.42
Revenue Estimate 300.91M 306.09M 266.67M 302.51M
Revenue Actual 304.58M 317.65M 295.47M 250.87M

To track all earnings releases for Conmed visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Levi Strauss & Co Reports Better-Than-Expected Q1 Results, Raises FY24 Guidance

By Erica Kollmann
April 3, 4:51 PM
The company reported quarterly earnings of 26 cents per share which beat the analyst consensus estimate of 21 cents by 23.81%. Quarterly sales came in at $1.558 billion which beat the analyst consensus estimate of $1.547 billion and is a 7.76% decrease over sales of $1.689 billion the same period last year. Levi Strauss reported total inventories decreased 14% on a dollar basis as of Feb. 25, and direct-to-consumer net revenues increased 7% on a reported basis.

LEVI